Gender representation in cardiothoracic surgical academia: A call to support women across the globe
- PMID: 39321869
- DOI: 10.1016/j.jtcvs.2024.09.032
Gender representation in cardiothoracic surgical academia: A call to support women across the globe
Keywords: authorship; career mobility; gender equity; leadership; surgeons; workforce.
Conflict of interest statement
Conflict of Interest Statement D.M.: AstraZeneca, J&J, Boston Scientific, Boehringer, BMS, Ideology Health, Merck (speaker and advisory board); CP: AstraZeneca (speaker/advisory board), J&J (speaker/advisory board), Medela (speaker); I.O.: Roche (institutional grant), Roche Genentech (steering committee), AstraZeneca (advisory board), MSD (advisory board), BMS (advisory board), Medtronic (institutional grant and advisory board), Intuitive (proctorship and speakers fee), Sanofi (speakers fee), Regeneron (advisory board), XVIVO (institutional grant), Siemens (speakers fee); S.F.: Gore and Edwards (consultancy); L.B.: Genentech/Roche (advisory panel), Astra Zeneca (speaker/advisory panel), Ethicon (advisory panel/consultant), Bristol Myers Squibb (advisory panel), MJH (speaker/advisory panel); M.B.A.: Merck, Astra Zeneca, Bristol Myers Squibb, and J&J (advisory panel); P.U.: AstraZeneca, Medtronic (advisory panel, speaker), MSD, Bristol Myers Squibb, J&J (speaker). All other authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous